Physician profile
Mary Suzanne Stevens
NPI 1811931231
$156,185.57
in general payments reported to CMS, 2019-2025
16 companies · $2,608 in 2025
The $2,608 reported for 2025 was more than what 83% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $15K · 2021: $4,396 · 2022: $13K · 2023: $68K · 2024: $35K · 2025: $2,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Consulting Fee: $29K · Travel and Lodging: $9,003 · Food and Beverage: $5,156 · Honoraria: $4,000 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,900 · Education: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,999.00 |
| Consulting Fee | $28,956.50 |
| Travel and Lodging | $9,002.72 |
| Food and Beverage | $5,156.13 |
| Honoraria | $4,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,900.00 |
| Education | $346.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $77,956.59 | 2019-2025 | Xywav |
| Inspire Medical Systems, INC. | $40,851.97 | 2019-2025 | Inspire |
| Harmony Biosciences LLC | $36,239.05 | 2020-2024 | Wakix |
| Ironshore Pharmaceuticals INC. | $256.84 | 2022-2024 | Jornay Pm |
| Axsome Therapeutics, INC. | $193.83 | 2023-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $148.07 | 2023-2024 | Lumryz |
| Azurity Pharmaceuticals, INC. | $146.38 | 2023-2024 | Horizant, Horizant |
| Tris Pharma INC | $124.90 | 2023 | Quillichew Er, Dyanavel Xr, Quillivant |
| Arbor Pharmaceuticals, INC. | $89.16 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $68.56 | 2023-2024 | Quviviq |
| Resmed Corp | $44.71 | 2023 | |
| Corium, LLC | $19.36 | 2023 | Azstarys |
| Grt US Holding, INC. | $16.13 | 2020 | |
| Noven Therapeutics, LLC | $14.05 | 2024 | Xelstrym |
| Philips North America LLC | $12.75 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $3.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.